Atlas Trials

Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses

Clinical trial NCT04380779 · COMPLETED

Trial details

NCT number
NCT04380779
Sponsor
Manuel Monreal
Status
COMPLETED
Study type
OBSERVATIONAL
COVID-19
Start date
2020-04-13
Primary completion
2020-10-13
Enrollment
2430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.